Richard Drew/AP/File
The Pfizer logo appears on a screen above its trading post on the floor of the New York Stock Exchange (April 6, 2016). The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland, on paper, to reduce its tax bill.